Finance

Lists
Why is JBIO up 2,38%?
Dive Deeper
JBIO:NASDAQ
Jade Biosciences Inc
13,76 $
+2,38%
(+0,32) 1D
15 հոկ, 14:26:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JBIO...
Open
13,54 $
High
14,18 $
Low
13,45 $
Mkt. cap
875,10 մլն
Avg. vol.
1,04 մլն
Volume
423,50 հզր
52-wk high
27,96 $
52-wk low
8,36 $
EPS
-2,31 $
Beta
1,64
Shares outstanding
63,60 մլն
No. of employees
55
Open
13,54 $
High
14,18 $
Low
13,45 $
Mkt. cap
875,10 մլն
Avg. vol.
1,04 մլն
Volume
423,50 հզր
52-wk high
27,96 $
52-wk low
8,36 $
EPS
-2,31 $
Beta
1,64
Shares outstanding
63,60 մլն
No. of employees
55
News stories
From web sources and news partners
About Jade Biosciences Inc
CEO-
Employees55
Founded2024
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitejadebiosciences.com
Analyst ratings
Based on 10 analysts giving stock ratings to JBIO in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for JBIO in the last 3 months.
Highest
Current 13,76 $
77,00 $ (+459,59%)
Average
50,50 $ (+267,01%)
Lowest
40,00 $ (+190,70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
47,00 $
+241,6%
10/01/2026
David Nierengarten
Wedbush
Buy
Maintained
47,00 $
+241,6%
10/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
55,00 $
+299,7%
10/01/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
09/30/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
42,00 $
+205,2%
09/30/2026
Kaveri Pohlman
Clear Street
Buy
Reiterated
48,00 $
+248,8%
09/04/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
40,00 $
+190,7%
08/13/2026
Akash Tewari
Jefferies
Buy
Maintained
48,00 $
+248,8%
08/11/2026
Laura Chico
Wedbush
Buy
Maintained
47,00 $
+241,6%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
77,00 $
+459,6%
08/10/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/10/2026
Michael Yee
UBS
Buy
Initiated
45,00 $
+227%
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,01 մլն
28,54 մլն
36,05 մլն
50,06 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 մլն
6,44 մլն
7,39 մլն
8,85 մլն
Operating expense
27,40 մլն
34,98 մլն
43,44 մլն
58,92 մլն
Total operating expenses
27,40 մլն
34,98 մլն
43,44 մլն
58,92 մլն
Operating income
-27,40 մլն
-34,98 մլն
-43,44 մլն
-58,92 մլն
Other non operating income
-28,00 հզր
20,00 հզր
-9,00 հզր
-62,00 հզր
EBT including unusual items
-25,18 մլն
-31,87 մլն
-40,35 մլն
-55,75 մլն
EBT excluding unusual items
-25,18 մլն
-31,87 մլն
-40,35 մլն
-55,75 մլն
Income tax expense
-
58,00 հզր
16,00 հզր
15,00 հզր
Effective tax rate
-
-0,18%
-0,04%
-0,03%
Other operating expenses
-
-
-
-
Net income
-25,18 մլն
-31,93 մլն
-40,37 մլն
-55,76 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0,76
Interest and investment income
2,25 մլն
3,08 մլն
3,10 մլն
3,23 մլն
Interest expense
-
-
-
-
Net interest expenses
2,25 մլն
3,08 մլն
3,10 մլն
3,23 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,39 մլն
-34,97 մլն
-43,44 մլն
-58,91 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps